Latest news with #adults
The Verge
18 hours ago
- Entertainment
- The Verge
YouTube is raising the minimum age for live streaming.
YouTube is raising the minimum age for live streaming. As of July 22nd, teens will have to be at least 16 years old to live stream on the platform, according to a support post. If a teen 13-15 years old wants to appear in a live stream, they'll have to have to be 'visibly accompanied' by an adult.
Yahoo
a day ago
- Health
- Yahoo
People Who Drink This Popular Beverage Have 2x the Risk of Diabetes, Study Finds
There's something about a crisp soda on a hot summer day. If you're on a weight loss journey or trying to cut out sugar, it can be tempting to turn to diet drinks to curb your craving. It makes sense, especially given that high amounts of daily sugar have been linked to weight gain, low energy, and possibly a higher risk of cancer. But as it turns out, diet sodas may not be the better option we originally thought. In fact, they may raise your risk of diabetes in a similar way to regular soda, according to a new study. In the study, researchers looked at the data of more than 4,654 adults from the 30-year-long Coronary Artery Risk Development in Young Adults (CARDIA) study. The participants' diets were assessed at the beginning of the study and then again at the seven and 20-year researchers looked at several factors, but mostly the average intake of diet beverages, and artificial sweeteners like aspartame and sucralose. The researchers then broke the participants up based on the amount of substances they ingested. They then looked at the participants' risk of diabetes. In this case, they defined diabetes as having a fasting glucose level higher than 126 mg/dL, glucose of 200 mg/dL or higher after a glucose tolerance test, an A1C above 6.5 percent, or the use of diabetes medications at follow-up visits. Researchers found that individuals who consumed the most diet beverages had a 129 percent higher risk of diabetes compared to those who drank the least. "Higher intakes of diet beverages and saccharin were associated with an increased risk of incident diabetes," the study authors said. "These findings highlight the need to evaluate the long-term metabolic effects of [artificial sweeteners] on glucose metabolism." People Who Drink This Popular Beverage Have 2x the Risk of Diabetes, Study Finds first appeared on Men's Journal on Jun 26, 2025
Health Line
2 days ago
- Health
- Health Line
Oligodendroglioma
Oligodendroglioma is a rare tumor that develops in the brain with no known cause. It tends to have a higher survival rate compared to most other brain tumors, but early diagnosis and treatment are key. Oligodendroglioma belongs to a group of brain tumors called gliomas. Gliomas are primary tumors. This means they originated in the brain rather than spreading from elsewhere in the body. The National Brain Tumor Society reports that around 1.2% of all brain tumors are classified as an oligodendroglioma. They are typically divided into two types: grade 2 (slow growing) grade 3 (fast growing) Oligodendroglioma is more commonly diagnosed in adults, though young children can also be affected. Life expectancy and survival rate According to the American Cancer Society, the 5-year relative survival rate for people with an oligodendroglioma is as follows: 90% for those ages 22 to 44 years 82% for those ages 45 to 54 years 69% for those ages 55 to 64 years The relative survival rate suggests how long someone with a condition may live after receiving their diagnosis compared to someone without the condition of the same race, sex, and age over a specific time. This is different from overall survival rate, which is a percentage of people still alive for a specific time after receiving a diagnosis. It's most important to remember that these figures are estimates, and everyone is different. You can talk with your doctor about your specific condition. Several factors can affect your survival rate, including the grade of the tumor and how early it was diagnosed, as well as your overall health. Symptoms Oligodendroglioma can lead to a wide variety of symptoms. Seizure is the most common symptom — about 60% of people experience a seizure before receiving an oligodendroglioma diagnosis, according to the National Cancer Institute. Other symptoms include: headache cognitive changes weakness or numbness in the limbs issues with balance or movement However, the symptoms you experience can vary based on the size of the tumor and which part of your brain the tumor is growing in. What are the causes? There are no known causes of oligodendroglioma. Genetic changes are thought to play a role in the development of oligodendroglioma. Factors such as radiation exposure may also increase the risk of developing this type of tumor. Treatment options There are a number of treatment options available. You and your doctors will work together to decide what's the best course of action is in your case. Your medical team will base their decisions upon a number of factors, including: your overall health the grade and location of your tumor the final diagnosis given by a neurosurgeon Surgery Surgery is typically the first-line treatment for oligodendroglioma. The goal is to remove as much of the tumor as possible. Other treatment If the tumor cannot be completely removed with surgery, additional treatment may be used to avoid recurrence, such as: Radiation therapy: This involves the use of high energy rays. It's typically used after surgery to help kill any tiny fragments of the tumor that may remain. Chemotherapy: This treatment uses cytotoxic drugs to help kill cancer cells and can be used before and after radiotherapy. It's also useful for shrinking brain tumors, particularly those that cannot be surgically removed. Targeted therapy: This treatment can be used to slow tumor regrowth. Clinical trials: Your doctor may recommend enrolling in a clinical trial to test potential new treatment options. Antiseizure medication: If you experience seizures, these medications will likely be a part of your treatment plan. Outlook and recurrence The outlook for oligodendroglioma tumors depends on factors such as the tumor grade, the overall health of the person with the diagnosis, and how early the tumor was diagnosed. People who receive a diagnosis and begin treatment early have a higher chance of survival. Overall, those who have an oligodendroglioma tend to have a higher survival rate than most other brain tumors. Many treatment options are available, and oligodendroglioma appears to respond well to treatment. It's unusual to be able to completely remove the tumor, but it's possible to prolong the life of someone with an oligodendroglioma. Successful treatment plans often employ several methods. This reduces the chance that the tumor will recur. Like all other gliomas, oligodendroglioma has a very high rate of recurrence and often gradually increases in grade over time. Recurrent tumors are often treated with more aggressive forms of chemotherapy and radiation therapy.
BBC News
2 days ago
- General
- BBC News
How to report Deepfake images
According to Ofcom, 52% of adults in the UK get their news from social media. So it's really important we're able to spot fake news and AI generated images. Here is a guide on how to spot AI generated images. Here is a guide on how to sport fake news. Once you've realised an image or story is fake, here, external is how to report it.
Yahoo
5 days ago
- Health
- Yahoo
This dieting approach may be more effective than intermittent fasting, scientists say
Alternate-day fasting works better at boosting metabolism compared to both calorie restriction and intermittent fasting, a new study suggests. Nearly 2.5 billion adults, or about 43 per cent of the global adult population, are overweight, with around 890 million living with obesity, according to the World Health Organization. Doctors recommend weight loss for this segment of the population to reduce metabolic risk factors like high blood pressure, elevated cholesterol and increased blood sugar levels, all of which contribute to diabetes and heart disease. Intermittent fasting, which involves cycling between periods of eating and fasting on a regular schedule, is sometimes recommended as an alternative to traditional calorie-restricted diets for weight loss. This may include time-restricted eating, typically involving a 16-hour fasting period followed by an eight-hour eating window. Another form of fasting is alternate-day fasting, which involves a 24-hour fast every other day. But the health benefits of various forms of fasting compared to continuous caloric restriction and an unrestricted diet have remained largely unclear so far. In a new study, researchers analysed the results of 99 randomised clinical trials involving 6,582 adult men and women to compare the effects of intermittent fasting diets with continuous calorie restriction or unrestricted diets on body weight and metabolic risk factors. The study participants had an average body mass index of 31, and nearly 90 per cent had pre-existing health conditions. Researchers found that alternate-day fasting was the only dietary strategy which provided a modest benefit in reducing body weight compared to continuous calorie restriction. This form of fasting was also associated with lower levels of total and LDL, or 'bad' cholesterol compared to time-restricted eating. However, researchers noted that even alternate-day fasting did not meet the clinically significant threshold of at least 2kg of weight loss for individuals with obesity. They cautioned that 'longer-duration trials are needed to further substantiate these findings'. 'Additional high quality randomised clinical trials, with extended durations beyond 52 weeks, are needed to elucidate the long-term effects of these dietary strategies,' they said in the study, 'with greater emphasis between intermittent fasting and its impact on cardiometabolic health across diverse populations.' For now, they said, alternate-day fasting could be added to the therapeutic toolkit for managing weight and metabolic health. 'Intermittent fasting does not aim to replace other dietary strategies, but to integrate and complement them within a comprehensive, patient-centered nutritional care model,' they noted.
